comparemela.com

Latest Breaking News On - Applied biological materials - Page 2 : comparemela.com

The Top 25 Healthcare Technology Leaders of Vancouver for 2022

Cell Reprogramming Market Size Value Projected to Touch Around USD 618 00 Million by 2030, at 8 0% CAGR Growth: Polaris Market Research

Global Bioinformatics Market (2022 to 2027) - Featuring Bluebee Holding, Dassault Systems, DNAnexus and DNASTAR Among Others

A cell-based GEF assay reveals new substrates for DENN domains and a role for DENND2B in primary ciliogenesis

A cell-based GEF assay reveals new substrates for DENN domains and a role for DENND2B in primary ciliogenesis
science.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from science.org Daily Mail and Mail on Sunday newspapers.

[Full text] Investigating LncRNA PVT1 on diabetic nephropathy

6 Some studies revealed that lncRNAs are related to the development and progression of DN. 7–9 For example, lncRNA MALAT1 can regulate renal tubular epithelial pyroptosis by modulating miR-23c targeting of ELAVL1 in DN. 10 LncRNA Tug1 can regulate mitochondrial bioenergetics in DN. 3 Moreover, lncRNA PVT1 (PVT1) has been shown to be involved in accelerating the progression of DN by promoting ECM accumulation and increasing expression of fibronectin 1 (FN1). 11 However, the underlying mechanism of PVT1 on diabetic nephropathy remains unclear. MicroRNAs (miRNAs) are non-coding RNAs with 20–30 nucleotides that can bind to mRNA to regulate its protein expression. 12 Previous reports indicated that miRNA-325-3p can suppress inflammation and fibrosis in the progression of DN.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.